Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shugan Xiaoji Pills
- Development stage
- Unknown
- Lead developer
- Lanzhou Foci
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shugan Xiaoji Pills (舒肝消积丸) is a traditional Chinese medicine (TCM) product developed and manufactured by Lanzhou Foci. It was granted a new drug certificate in China in 2001. The formulation is designed according to TCM principles to 'soothe the liver' (Shugan) and 'eliminate accumulation' (Xiaoji), which clinically translates to treating chronic liver conditions. It is typically indicated for the treatment of chronic hepatitis, liver fibrosis, and early-stage cirrhosis by addressing liver qi stagnation and resolving physical masses or nodules. The medication is administered orally as a concentrated herbal pill.
- Brand names
- Shugan Xiaoji Pills
- Other names
- Shugan Xiaoji Wan舒肝消积丸
02
Targets
IL-6 (Interleukin 6)MMP9 (Matrix metalloproteinase-9)VEGFA (Vascular endothelial growth factor A)TNFA (Tumor necrosis factor alpha (soluble))RELA (Nuclear Factor Kappa B Subunit p65)IL1B (Interleukin-1 beta)
Beyond the preview
Go deeper on Shugan Xiaoji Pills.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shugan Xiaoji Pills.